Cyclo Therapeutics (CYTH) Reports Publication of Data from Phase 2 Study of Trappsol Cyclo streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
– Data published in official journal of Molecular Genetics and Metabolism Reports:
Evidence of a change in cholesterol homeostasis in peripheral organs and the brain after the initial infusion
Trappsol® Cyclo™ was detected in the CSF
Completers had an 88.9% improvement in at least two domains of the 17-Domain Niemann-Pick Type C1 Clinical Severity Scale (17D-NPC-CSS)
Improvement in Scale Assessment and Rating of Ataxia (SARA) score for the mean score in 7 of 8 domains at Week 48 compared with baseline
Demonstrated a favorable benefit-risk profile
IntraBio NPC Phase III Successful Trial clevelandstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clevelandstar.com Daily Mail and Mail on Sunday newspapers.
WU-CART-007 was well-tolerated in patients with R/R T-ALL/LBL, with low incidence of high-grade CRS and immune-related adverse events WU-CART-007 demonstrated preliminary evidence of anti-leukemic
RAINBOW study design enables rapid advancement into the company's planned Phase 3 efficacy trial Azafaros B.V. today announced that the first patient has been enrolled into its Phase 2 RAINBOW